UTHR
United Therapeutics Corporation
NASDAQ · Healthcare · Biotechnology · US
$487.61
−0.54%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.28x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- -1.09x
Liquidity & coverage
- Current ratio
- 5.73x
- Quick ratio
- 5.41x
- Cash ratio
- 4.38x
- Interest coverage
- 116.95x
- EBITDA / interest
- 137.69x
- Working capital
- $2.9B
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026